{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:23:33Z","timestamp":1789788213745,"version":"4.0.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["HHSN266200700023C"],"award-info":[{"award-number":["HHSN266200700023C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["N01-AI-70023"],"award-info":[{"award-number":["N01-AI-70023"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New and minimally invasive tools to aid the diagnosis of invasive fungal diseases (IFD) are urgently needed as the immunocompromised population at highest risk increases. Advancements in molecular technology have rendered new diagnostics more readily available for clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This case-control study used prospectively collected archived plasma specimens and data from the Aspergillus Technology Consortium Repository to investigate the diagnostic performance of microbial cell-free DNA (mcfDNA) sequencing as a minimally invasive diagnostic for IFDs in a population of high-risk immunocompromised hosts including hematologic malignancy, stem cell, and solid organ transplants patients. The 2008 Mycoses Study Group\/European Organization for the Research and Treatment of Cancer diagnostic criteria served as the gold standard for test performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-five adult subjects with proven or probable IFD and 65 controls without IFD were included. Among IFD episodes Aspergillus was the most common pathogen (70.8%, 46\/65), followed by Mucorales (10.8%, 7\/65). Overall, sensitivity was 47.7% and specificity was 100%. Sensitivity varied based on disease certainty and pathogen; sensitivity was higher in proven versus probable IFD (60.0% vs 37.1%, respectively) and higher for subjects with invasive mucormycosis (100%) compared with aspergillosis (45.7%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A positive result by mcfDNA sequencing may reduce the need for invasive sampling in patients with suspected IFD. In this exploratory analysis, its high sensitivity and specificity for invasive mucormycosis suggests it could be useful for early treatment and intervention of this IFD. Future studies should focus on understanding how specific factors impact the sensitivity of mcfDNA sequencing for invasive aspergillosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf170","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:47:42Z","timestamp":1743493662000},"page":"1008-1014","source":"Crossref","is-referenced-by-count":16,"title":["Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-4476","authenticated-orcid":false,"given":"Beatrice Z","family":"Sim","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan K","family":"Mah","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-1870","authenticated-orcid":false,"given":"Madeleine R","family":"Heldman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L","family":"Stanly","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9790-277X","authenticated-orcid":false,"given":"Kimberly E","family":"Hanson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine , Salt Lake City, Utah ,","place":["USA"]},{"name":"Section of Clinical Microbiology, Department of Pathology, University of Utah and ARUP Laboratories , Salt Lake City, Utah ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4309-7642","authenticated-orcid":false,"given":"Angela M","family":"Caliendo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Warren Alpert Medical School of Brown University , Providence, Rhode Island ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-9950","authenticated-orcid":false,"given":"David","family":"Andes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Wisconsin , Madison, Wisconsin ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Texas Medical School at Houston , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-5398","authenticated-orcid":false,"given":"John R","family":"Wingard","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Florida College of Medicine , Gainesville, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara D","family":"Alexander","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025122403224292000_ciaf170-B1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1399-3062.1999.010404.x","article-title":"Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century","volume":"1","author":"Walsh","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"2025122403224292000_ciaf170-B2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11908-014-0415-z","article-title":"Update on fungal diagnostics","volume":"16","author":"Griffin","year":"2014","journal-title":"Curr Infect Dis Rep"},{"key":"2025122403224292000_ciaf170-B3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/cid\/ciad599","article-title":"Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: a prospective observational study","volume":"78","author":"Bergin","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.cmi.2024.03.003","article-title":"Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematological malignancies","volume":"30","author":"Park","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2025122403224292000_ciaf170-B5","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2025122403224292000_ciaf170-B6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/bmt.2009.203","article-title":"Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation","volume":"45","author":"Shannon","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"2025122403224292000_ciaf170-B9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"2025122403224292000_ciaf170-B10","doi-asserted-by":"crossref","first-page":"e27734","DOI":"10.1002\/pbc.27734","article-title":"Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease","volume":"66","author":"Armstrong","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"2025122403224292000_ciaf170-B11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/ciab324","article-title":"Plasma microbial cell-free DNA next generation sequencing in the diagnosis and management of febrile neutropenia","volume":"74","author":"Benamu","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B12","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.12688\/f1000research.19766.3","article-title":"Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts","volume":"8","author":"Camargo","year":"2019","journal-title":"F1000Res"},{"key":"2025122403224292000_ciaf170-B13","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025122403224292000_ciaf170-B14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamaoncol.2019.4120","article-title":"Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer","volume":"6","author":"Goggin","year":"2020","journal-title":"JAMA Oncol"},{"key":"2025122403224292000_ciaf170-B15","doi-asserted-by":"crossref","first-page":"e3876","DOI":"10.1093\/cid\/ciaa1639","article-title":"Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free DNA in plasma","volume":"73","author":"Hill","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease","volume":"92","author":"Hong","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025122403224292000_ciaf170-B17","doi-asserted-by":"crossref","first-page":"ofae252","DOI":"10.1093\/ofid\/ofae252","article-title":"Diagnostic value of microbial cell-free DNA sequencing for suspected invasive fungal infections: a retrospective multicenter cohort study","volume":"11","author":"Huygens","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2025122403224292000_ciaf170-B18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Froup and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B20","volume-title":"Performance standards for antifungal susceptibility testing of yeasts. 3rd ed. CLSI supplement M27M44S","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2022"},{"key":"2025122403224292000_ciaf170-B21","volume-title":"Performance standards for antifungal susceptibility testing of filamentous fungi. 3rd ed. CLSI supplement M3851S","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2022"},{"key":"2025122403224292000_ciaf170-B22","volume-title":"Epidemiologic cutoff values for antifugnal susceptibiltiy testing. 4th ed. CLSI supplement M57S","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2022"},{"issue":"1, Supplement","key":"2025122403224292000_ciaf170-B23","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.amjmed.2011.10.008","article-title":"Invasive mycoses: diagnostic challenges","volume":"125","author":"Ostrosky-Zeichner","year":"2012","journal-title":"Am J Med"},{"key":"2025122403224292000_ciaf170-B24","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/microorganisms9071518","article-title":"Microbiological and molecular diagnosis of mucormycosis: from old to new","volume":"9","author":"Lackner","year":"2021","journal-title":"Microorganisms"},{"key":"2025122403224292000_ciaf170-B25","doi-asserted-by":"crossref","first-page":"e00746-18","DOI":"10.1128\/JCM.00746-18","article-title":"PCR-based approach targeting Mucorales-specific gene family for diagnosis of mucormycosis","volume":"56","author":"Baldin","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2025122403224292000_ciaf170-B26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B27","doi-asserted-by":"crossref","first-page":"ofab441","DOI":"10.1093\/ofid\/ofab441","article-title":"Impact of changes of the 2020 consensus definitions of invasive aspergillosis on clinical trial design: unintended consequences for prevention trials?","volume":"8","author":"Wingard","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025122403224292000_ciaf170-B28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cmi.2022.02.026","article-title":"The impact of the updated EORTC\/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis","volume":"28","author":"Lamberink","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2025122403224292000_ciaf170-B29","doi-asserted-by":"crossref","first-page":"101304","DOI":"10.1016\/j.mycmed.2022.101304","article-title":"Impact of revised EORTC\/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy","volume":"32","author":"Acet-\u00d6zt\u00fcrk","year":"2022","journal-title":"J Med Mycol"},{"key":"2025122403224292000_ciaf170-B30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jof7010027","article-title":"A prospective multicenter cohort surveillance study of invasive aspergillosis in patients with hematologic malignancies in Greece: impact of the revised EORTC\/MSGERC 2020 criteria","volume":"7","author":"Siopi","year":"2021","journal-title":"J Fungi"},{"key":"2025122403224292000_ciaf170-B31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3390\/jof8121307","article-title":"The use of host biomarkers for the management of invasive fungal disease","volume":"8","author":"Griffiths","year":"2022","journal-title":"J Fungi (Basel)"},{"issue":"Supplement_1","key":"2025122403224292000_ciaf170-B32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13693780600904918","article-title":"Issues with galactomannan testing","volume":"44","author":"Verweij","year":"2006","journal-title":"Med Mycol"},{"key":"2025122403224292000_ciaf170-B33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.patbio.2011.10.011","article-title":"Clinical utility and prognostic value of galactomannan in neutropenic patients with invasive aspergillosis","volume":"60","author":"Hadrich","year":"2012","journal-title":"Pathol Biol (Paris)"},{"key":"2025122403224292000_ciaf170-B34","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2025122403224292000_ciaf170-B36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1309\/UJRV9DLC11RM3G8R","article-title":"Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis","volume":"127","author":"Stergiopoulou","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"2025122403224292000_ciaf170-B37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/atm.2016.08.32","article-title":"The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"4","author":"Hites","year":"2016","journal-title":"Ann Transl Med"},{"key":"2025122403224292000_ciaf170-B38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025122403224292000_ciaf170-B39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/jiad255","article-title":"Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections after hematopoietic cell transplant","volume":"229","author":"Heldman","year":"2024","journal-title":"J Infect Dis"},{"key":"2025122403224292000_ciaf170-B40","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/JCM.00744-13","article-title":"Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis","volume":"51","author":"Lyon","year":"2013","journal-title":"J Clin Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf170\/62846639\/ciaf170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/1008\/62846639\/ciaf170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/5\/1008\/62846639\/ciaf170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:22:51Z","timestamp":1766564571000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/5\/1008\/8104460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf170","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,15]]},"published":{"date-parts":[[2025,4,3]]}}}